Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    0.00 (0.00%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Trading Update

22 Jan 2025 07:00

RNS Number : 1951U
Itaconix PLC
22 January 2025
 

For release on RNS: 22 January 2025

Itaconix plc

("Itaconix", the "Company" or the "Group")

Trading Update

Itaconix plc (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used to decarbonize everyday consumer products, is pleased to provide a trading update for the year ended 31 December 2024 which is in line with expectations.

Unaudited 2024 revenues of $6.5 million and an increase in unaudited gross profit margins to c. 35% from 31% in 2023. reflect the Company's success at adjusting market positioning in 2024. Revenue diversification has also improved significantly, with increased contributions from a wider array of products across a broader customer base. The Board believes the Company is well positioned for future revenue growth as a higher margin business, in furtherance of the Board's strategy to become a profitable specialty ingredient company.

The Cleaning Sector remains a key strength and leading source of revenue. European volumes continue to grow significantly as more detergent formulators and producers recognize the superior performance, cost efficiency, and sustainability benefits of Itaconix's plant-based detergent polymers. This growth partially offset the anticipated year-on-year ("y-o-y") decline in the North American Cleaning Sector as a result of the previously announced strategic move away from a low margin customer.

Increased volumes purchased by Croda and Nouryon led to sizable y-o-y revenue growth in the Hygiene and Beauty Sectors, respectively. The high relative value of Itaconix's odour neutralizing and hair styling ingredients contributed to improving the Company's overall gross profit margin.

The size and breadth of the Formulated Solutions business segment continue to grow. The Company is increasingly able to provide North American brands with new generations of consumer products. The SPARX™ program, aimed at fostering collaborative innovation with advanced specialty ingredient companies and end-product manufacturers, is developing well and is expected to introduce at least 10 new products and generate additional revenue opportunities in 2025.

The balance sheet remains strong with sufficient cash resources to fund future growth. Unaudited net cash and investments as at 31 December 2024 were $6.7 million (2023: $10.0 million), which reflects investments in new marketing capabilities, new products, additional product studies and global regulatory approvals as well as a step up in inventory levels to support substantial current and expected increases in European revenues.

Itaconix is proud of its Environmental, Social, and Governance (ESG) impact and its 2023 ESG report is available for investors to review on the Company website. Visit www.itaconix.com to download the report.

Overall, the Board remains optimistic about the Company's prospects for 2025, driven by increasing customer and consumer awareness of the efficacy, cost benefits, and sustainability of its products. The new year has started strongly, although the Board remains mindful of current macroeconomic and geopolitical risks, including a potential for increased tariffs on key raw materials that the Company sources from Asia.

Further details of 2024 trading and the latest outlook for 2025 will be provided when the Company announces FY24 results by early April.

John R. Shaw, CEO of Itaconix, commented:

"We have ended 2024 in a strong position, with trading in line with expectations and continued progress in diversifying our revenues. Our growth in Europe, customer diversification, and the development of our SPARX™ program underpin our optimism for 2025. We remain committed to delivering sustainable solutions that meet evolving customer needs while carefully navigating external risks. With a solid balance sheet and a growing customer base, we are confident in our ability to sustain growth and create long-term value."

- Ends -

Enquiries:

Itaconix plc +1 603 775 4400

John R. Shaw / Laura Denner

Rosewood +44 (0) 207 653 8704

Financial PR

John West / Llew Angus

Canaccord Genuity +44 (0) 7523 8000

Nominated Adviser and Broker

Adam James / Harry Pardoe

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's products contribute to the global low carbon economy.

www.itaconix.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDBGDBIUDDGUB
Date   Source Headline
19th May 20207:00 amRNSNew Loan Funding
5th May 20209:05 amRNSSecond Price Monitoring Extn
5th May 20209:00 amRNSPrice Monitoring Extension
5th May 20207:00 amRNSStrong Revenue Momentum and Extended Funding
17th Mar 20207:00 amRNSCompany Update on Funding and Business Plan
4th Mar 20207:00 amRNSNew Collaboration in Biodegradable Packaging
25th Feb 20207:00 amRNSOrder for Sustainable Detergent Ingredient
20th Feb 20207:00 amRNSHolding(s) in Company
20th Feb 20207:00 amRNSHolding(s) in Company
18th Feb 20202:49 pmRNSHolding(s) in Company
18th Feb 20209:31 amRNSBlock listing Interim Review
12th Feb 20207:15 amRNSNew Supply and License Agreements with New Wave
10th Feb 20207:00 amRNSNew BIO*AsterixT Product Line
28th Jan 20207:00 amRNSIntroduction of New Detergent Polymer
21st Jan 20202:14 pmRNSHolding(s) in Company
17th Jan 20207:00 amRNSTermination of Chelates Agreement
9th Jan 20207:00 amRNSFull Year Trading Update
8th Jan 20207:00 amRNSNew patent issued for detergent compositions
7th Jan 20207:00 amRNSFirst order to Croda for new odour control polymer
18th Dec 20198:00 amRNSCommencement of Trading on US OTCQB Market
24th Oct 20197:00 amRNSExpansion of Croda Supply & Joint Marketing Agrmt
23rd Oct 20197:00 amRNSIntroduction of New Odour Control Product Line
21st Oct 20195:57 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSTrading Update
27th Sep 20197:00 amRNSRecognition from Biofuels Digest
16th Sep 20195:11 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSInterim results
30th Aug 20193:17 pmRNSHolding(s) in Company
30th Aug 20197:00 amRNSAppointment of New Chief Financial Officer
22nd Aug 201911:05 amRNSSecond Price Monitoring Extn
22nd Aug 201911:00 amRNSPrice Monitoring Extension
20th Aug 20197:00 amRNSHolding(s) in Company
16th Aug 20199:00 amRNSPrice Monitoring Extension
6th Aug 20194:50 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSPDMR Shareholding
2nd Aug 20192:05 pmRNSSecond Price Monitoring Extn
2nd Aug 20192:00 pmRNSPrice Monitoring Extension
2nd Aug 201911:05 amRNSSecond Price Monitoring Extn
2nd Aug 201911:00 amRNSPrice Monitoring Extension
29th Jul 20196:03 pmRNSBlock listing Interim Review
19th Jul 20193:28 pmRNSResult of AGM
17th Jul 20197:00 amRNSHalf-Year Trading Update
10th Jul 20194:41 pmRNSSecond Price Monitoring Extn
10th Jul 20194:35 pmRNSPrice Monitoring Extension
9th Jul 20195:19 pmRNSHolding(s) in Company
27th Jun 20197:00 amRNSPreliminary Results
14th Jun 20197:00 amRNSNotice of Results
29th May 20197:00 amRNSSale of Minority Interest in Alkalon
21st May 20197:00 amRNSFirst personal care purchase order from Nouryon
20th May 20197:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.